Dennis Yiannakis

Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials

Ignace Vergote, Corneel Coens, Matthew Nankivell et al. · The Lancet Oncology · 2018 · 290 citations · Full text

Surgical Oncology, Gynecological Surgery, Individual Patient Data +10

Resistance gene expression determines the in vitro chemosensitivity of non-small cell lung cancer (NSCLC)

Sharon Glaysher, Dennis Yiannakis, Francis G Gabriel et al. · BMC Cancer · 2009 · 38 citations · Full text

EGFR targeted therapy in lung cancer; an evolving story

Catherine Bartholomew, Leonie Eastlake, Po Dunn et al. · Respiratory Medicine Case Reports · 2017 · 36 citations · Full text

BRCA1 deficiency increases the sensitivity of ovarian cancer cells to auranofin

Deepu Oommen, Dennis Yiannakis, Awadhesh N. Jha · Mutation research. Fundamental and molecular mechanisms of mutagenesis · 2015 · 28 citations

Oncogenic Agent, Medicine, Pathology +9

Niraparib as maintenance therapy in a patient with ovarian cancer and brain metastases

Simon Gray, Xiao ying Khor, Dennis Yiannakis · BMJ Case Reports · 2019 · 23 citations · Full text